
KORU Medical Systems, Inc.
KRMDNasdaqCIK 704440HealthcareFiscal year ends Dec 31
Reports and events: 233 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-08-0916:20 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001161697-23-000443 |
| 2023-08-0916:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-23-000441 |
| 2023-08-0217:19 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001161697-23-000429 |
| 2023-06-2707:40 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001161697-23-000378 |
| 2023-05-1717:22 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001161697-23-000302 |
| 2023-05-0416:15 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001161697-23-000281 |
| 2023-05-0416:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-23-000280 |
| 2023-03-2917:25 ET | DEF 14A | Proxy statementPeriod 2023-05-17 | 0001161697-23-000194 |
| 2023-03-0816:38 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001161697-23-000158 |
| 2023-03-0816:27 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-23-000156 |
| 2023-02-2416:10 ET | SC 13D/A | Ownership report, active investor, amended | 0001161697-23-000144 |
| 2022-11-0916:39 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001161697-22-000538 |
| 2022-11-0916:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-22-000537 |
| 2022-08-0316:29 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001161697-22-000377 |
| 2022-08-0316:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-22-000375 |
| 2022-07-0617:21 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001161697-22-000345 |
| 2022-06-2817:06 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001161697-22-000325 |
| 2022-05-1816:30 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001161697-22-000259 |
| 2022-05-1017:00 ET | 8-K | 5.07 Shareholder vote results | 0001161697-22-000232 |
| 2022-05-0416:29 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001161697-22-000216 |
| 2022-05-0416:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-22-000215 |
| 2022-03-1816:15 ET | DEF 14A | Proxy statementPeriod 2022-05-06 | 0001161697-22-000140 |
| 2022-03-0216:03 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001161697-22-000133 |
| 2022-03-0216:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-22-000132 |
| 2021-12-1008:23 ET | 8-K | 7.01 Regulation FD disclosure | 0001161697-21-000572 |
| 2021-12-0709:07 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001161697-21-000567 |
| 2021-11-1017:17 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001161697-21-000525 |
| 2021-11-1016:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-21-000521 |
| 2021-08-1117:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-21-000375 |
| 2021-08-1117:07 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001161697-21-000374 |
| 2021-05-1916:24 ET | 8-K | 5.07 Shareholder vote results | 0001161697-21-000276 |
| 2021-05-1216:06 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001161697-21-000247 |
| 2021-05-1216:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-21-000246 |
| 2021-04-0607:40 ET | SC 13D/A | Ownership report, active investor, amended | 0001161697-21-000202 |
| 2021-04-0516:05 ET | DEF 14A | Proxy statementPeriod 2020-12-31 | 0001161697-21-000196 |
| 2021-03-2316:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-21-000171 |
| 2021-03-2316:01 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001161697-21-000169 |
| 2021-03-1908:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001161697-21-000160 |
| 2021-02-1117:09 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001161697-21-000091 |
| 2021-01-2618:29 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001161697-21-000074 |
| 2020-11-1709:19 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001161697-20-000493 |
| 2020-11-1717:48 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001161697-20-000491 |
| 2020-11-1216:38 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001161697-20-000481 |
| 2020-11-0421:59 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-20-000471 |
| 2020-08-2016:01 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-20-225628 |
| 2020-08-0516:31 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001161697-20-000352 |
| 2020-08-0518:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-20-000349 |
| 2020-06-2217:06 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001161697-20-000252 |
| 2020-06-1816:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001161697-20-000247 |
| 2020-05-2612:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001161697-20-000226 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 11, 2026, 02:24 ET. Listed shows no prices and gives no investment advice.